These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 17965124)

  • 1. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.
    van der Helm-van Mil AH; van der Kooij SM; Allaart CF; Toes RE; Huizinga TW
    Ann Rheum Dis; 2008 Jun; 67(6):769-74. PubMed ID: 17965124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.
    Rojas-Villarraga A; Diaz FJ; Calvo-Páramo E; Salazar JC; Iglesias-Gamarra A; Mantilla RD; Anaya JM
    J Autoimmun; 2009 Feb; 32(1):64-9. PubMed ID: 19117726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.
    Welsing PM; van Gestel AM; Swinkels HL; Kiemeney LA; van Riel PL
    Arthritis Rheum; 2001 Sep; 44(9):2009-17. PubMed ID: 11592361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.
    van Oosterhout M; Bajema I; Levarht EW; Toes RE; Huizinga TW; van Laar JM
    Arthritis Rheum; 2008 Jan; 58(1):53-60. PubMed ID: 18163491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.
    van der Helm-van Mil AH; Huizinga TW; Schreuder GM; Breedveld FC; de Vries RR; Toes RE
    Arthritis Rheum; 2005 Sep; 52(9):2637-44. PubMed ID: 16142711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity has a protective effect on radiographic joint damage in rheumatoid arthritis].
    Tekaya R; Sahli H; Zribi S; Mahmoud I; Ben Hadj Yahia C; Abdelmoula L; Chaabouni L; Zouari R
    Tunis Med; 2011 May; 89(5):462-5. PubMed ID: 21557184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies.
    Tamai M; Kawakami A; Uetani M; Takao S; Arima K; Iwamoto N; Fujikawa K; Aramaki T; Kawashiri SY; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
    Arthritis Rheum; 2009 Jun; 61(6):772-8. PubMed ID: 19479686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation.
    Escalante A; Haas RW; del Rincón I
    Arch Intern Med; 2005 Jul; 165(14):1624-9. PubMed ID: 16043681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis.
    Jacobsen S; Garred P; Madsen HO; Heegaard NH; Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Smedegaard Andersen L; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Vestergaard A; Østergaard M; Hørslev-Petersen K
    J Rheumatol; 2009 Apr; 36(4):731-5. PubMed ID: 19273450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
    Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
    Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
    Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
    J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
    Bos WH; Ursum J; de Vries N; Bartelds GM; Wolbink GJ; Nurmohamed MT; van der Horst-Bruinsma IE; van de Stadt RJ; Crusius JB; Tak PP; Dijkmans BA; van Schaardenburg D
    Ann Rheum Dis; 2008 Sep; 67(9):1347-50. PubMed ID: 18388157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis.
    Tolboom TC; van der Helm-Van Mil AH; Nelissen RG; Breedveld FC; Toes RE; Huizinga TW
    Arthritis Rheum; 2005 Jul; 52(7):1999-2002. PubMed ID: 15986342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.